Metabolic production of amphetamine following multidose administration of clobenzorex.
The interpretation of urine drug-testing results can have important forensic and legal implications. In particular, drugs that are metabolized to amphetamine or methamphetamine or both pose significant concerns. In this study, clobenzorex, an anorectic drug that is metabolized to d-amphetamine, was administered to five subjects. Each subject took 30 mg daily for seven days, and individual urine samples were collected ad lib for 14 days beginning on the first day the drug was administered. Urine pH, specific gravity, and creatinine values were determined for each sample. Gas chromatography-mass spectrometry (GC-MS) was used to determine the excretion profile of amphetamine and clobenzorex using a standard procedure for amphetamines with additional monitoring of ions at m/z 118, 125, and 364 for the detection of clobenzorex. Peak concentrations of amphetamine were found at 82 to 168 h after the first dose and ranged from approximately 2900 to 4700 ng/mL amphetamine. The use of a regioisomer (3-Cl-benzylamphetamine) as internal standard allowed for accurate quantitation of the parent drug. Peak concentrations of clobenzorex were found at 50 to 120 h after the first dose and ranged from approximately 8 to 47 ng/mL clobenzorex. However, in many samples, clobenzorex was not detected at all. This analysis revealed that the metabolite, (amphetamine) is present in much higher concentrations than the parent compound, clobenzorex. Yet even at peak amphetamine concentrations, the parent was not always detected (limit of detection 1 ng/mL). Thus, in the interpretation of amphetamine-positive drug-testing results, the absence of clobenzorex in the urine sample does not exclude the possibility of its use.
Baden
K L
KL
Department of Internal Medicine, Lackland AFB, Texas 78236-5319, USA.
Valtier
S
S
Cody
J T
JT
D000661:Amphetamine / Q000652:urine*; D000662:Amphetamines / Q000008:administration & dosage / Q000378:metabolism / Q000652:urine*; D001067:Appetite Depressants / Q000008:administration & dosage / Q000378:metabolism*; D001589:Benzphetamine / Q000031:analogs & derivatives / Q000737:chemistry; D003404:Creatinine / Q000652:urine*; D005260:Female; D008401:Gas Chromatography-Mass Spectrometry; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008297:Male; D013046:Specific Gravity; D015813:Substance Abuse Detection / Q000379:methods; D013997:Time Factors; D014556:Urine / Q000737:chemistry*
D000662:Amphetamines; D001067:Appetite Depressants; D001589:Benzphetamine; C000490:clobenzorex; C015024:benzylamphetamine; D003404:Creatinine; D000661:Amphetamine